Featured Tickers:
Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Surgery Partners, Inc., Progyny or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.
Read on to learn how Surgery Partners, Inc., Progyny and Inc. compare based on key financial metrics to determine which better meets your investment needs.
About Surgery Partners, Inc., Progyny and Inc.
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Latest Health Care Providers & Services and Surgery Partners, Inc., Progyny, Inc. Stock News
As of May 5, 2025, Surgery Partners, Inc. had a $3.0 billion market capitalization, compared to the Health Care Providers & Services median of $1.1 million. Surgery Partners, Inc.’s stock is up 8.7% in 2025, up 3% in the previous five trading days and down 4.71% in the past year.
Currently, Surgery Partners, Inc. does not have a price-earnings ratio. Surgery Partners, Inc.’s trailing 12-month revenue is $3.1 billion with a -5.4% net profit margin. Year-over-year quarterly sales growth most recently was 17.5%. Analysts expect adjusted earnings to reach $1.039 per share for the current fiscal year. Surgery Partners, Inc. does not currently pay a dividend.
As of May 5, 2025, Progyny, Inc. had a $2.0 billion market cap, putting it in the 59th percentile of all stocks. Progyny, Inc.’s stock is up 35.4% in 2025, up 1.7% in the previous five trading days and down 27.53% in the past year.
Currently, Progyny, Inc.’s price-earnings ratio is 41.1. Progyny, Inc.’s trailing 12-month revenue is $1.2 billion with a 4.7% net profit margin. Year-over-year quarterly sales growth most recently was 10.6%. Analysts expect adjusted earnings to reach $1.604 per share for the current fiscal year. Progyny, Inc. does not currently pay a dividend.
How We Compare Surgery Partners, Inc., Progyny and Inc. Stock Grades
Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.
AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Surgery Partners, Inc., Progyny and Inc.’s stock grades to see how they measure up against one another.
Learn more about A+ Investor here!
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions